Collegium Pharmaceutical, Inc. (COLL): Price and Financial Metrics

COLL POWR Grades

• Growth is the dimension where COLL ranks best; there it ranks ahead of 99.06% of US stocks.
• The strongest trend for COLL is in Stability, which has been heading down over the past 177 days.
• COLL ranks lowest in Momentum; there it ranks in the 7th percentile.

COLL Stock Summary

• With a year-over-year growth in debt of 174.08%, COLLEGIUM PHARMACEUTICAL INC's debt growth rate surpasses 92.35% of about US stocks.
• As for revenue growth, note that COLL's revenue has grown 67.56% over the past 12 months; that beats the revenue growth of 88.8% of US companies in our set.
• COLLEGIUM PHARMACEUTICAL INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -54.39%, greater than the shareholder yield of only 10.14% of stocks in our set.
• Stocks that are quantitatively similar to COLL, based on their financial statements, market capitalization, and price volatility, are CMP, NMIH, GRIN, HLX, and CDZI.
• Visit COLL's SEC page to see the company's official filings. To visit the company's web site, go to www.collegiumpharma.com.

COLL Valuation Summary

• COLL's price/sales ratio is 1.7; this is 10.53% lower than that of the median Healthcare stock.
• COLL's EV/EBIT ratio has moved up 53.5 over the prior 96 months.

Below are key valuation metrics over time for COLL.

COLL Growth Metrics

Its 3 year net income to common stockholders growth rate is now at 241.79%.
• Its 4 year net income to common stockholders growth rate is now at 87.63%.
• The 3 year net cashflow from operations growth rate now stands at -56.03%.

COLL's revenue has moved up $64,974,000 over the prior 33 months.

The table below shows COLL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	361.675	94.103	-42.837
2022-06-30	313.505	68.588	-35.248
2022-03-31	272.898	57.672	42.786
2021-12-31	276.868	103.557	71.517
2021-09-30	325.777	89.936	103.509
2021-06-30	326.11	106.862	106.749

COLL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• COLL has a Quality Grade of B, ranking ahead of 83.9% of graded US stocks.
• COLL's asset turnover comes in at 0.493 -- ranking 87th of 681 Pharmaceutical Products stocks.
• IBIO, IRWD, and COCP are the stocks whose asset turnover ratios are most correlated with COLL.

The table below shows COLL's key quality metrics over time.